Navigation Links
GeneTex to Release New Antibodies for the Study of DNA Repair in Zebrafish
Date:3/14/2013

IRVINE, Calif., March 14, 2013 /PRNewswire/ -- GeneTex, a leading manufacturer of high-quality antibodies, is pleased to announce that it will be launching new antibodies against phosphorylated Histone H2A.X and p53 designed for use with zebrafish samples.

(Photo: http://photos.prnewswire.com/prnh/20111129/LA13485LOGO-b)

The zebrafish is being increasingly utilized as a model organism to study DNA repair. The zebrafish genome contains nearly all of the genes involved in the different DNA repair pathways, including the genes for the components of the p53-mediated damage recognition pathway. Furthermore, the embryos can easily be treated with UV or ionizing irradiation to induce DNA damage.  Importantly, the study of individual DNA damage recognition and repair factors is possible with shRNA- or morpholino-based approaches that are established techniques in the zebrafish field.

GeneTex is excited to contribute to zebrafish DNA damage recognition and repair research by offering these two new antibodies. Phosphorylated histone H2A.X is extremely useful as an early marker of double-strand breaks that can be used to assess the extent of DSB repair. The p53 antibody will be immensely valuable for those researchers studying DNA damage and apoptotic mechanisms, with the logical extension into tumorigenesis. These two reagents represent just the beginning of GeneTex's efforts to establish a diverse catalog of antibody products that perform in the zebrafish system. Therefore, GeneTex is pleased to announce the launch of these new antibodies against phosphorylated H2A.X and p53 that have been developed specifically for use with zebrafish.

GeneTex's Histone H2A.X (phospho Ser139) antibody has been validated for immunohistochemistry using both whole-mount and paraffin-embedded zebrafish embryos. The p53 antibody has been validated for western blotting and immunohistochemistry using zebrafish tissues. UV irradiation results in a marked increase in the intensity of the signal detected by both products, which demonstrates the specificity of these antibodies. For additional information on GeneTex, Inc. and its zebrafish antibodies, please call toll-free 877-GENETEX (436-3839) or visit www.genetex.com/zebrafish.

About GeneTex, Inc.

GeneTex, Inc. is an antibody company founded in 1997 by a group of internationally renowned academic scientists. They strive to produce the highest-quality antibodies and reagents. Their primary and secondary antibodies are created through a process involving extensive research, development and validation.  GeneTex's catalog has grown to over 55,000 primary antibodies and all are backed by a 100% Satisfaction Guarantee. 

Corporate Mission

We strive to serve and accelerate life science research by creating essential life science tools where quality can be found in every vial.


'/>"/>
SOURCE GeneTex
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. GeneTex, Inc. to Launch a New Primary Antibody against HIF1a
2. ulrich medical USA™ Releases New Expandable Spinal Implant for US Market
3. Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012
4. STAAR Surgical Announces First Quarter 2012 Results Release Date and Conference Call and Webcast
5. Upsher-Smith Research Shows Unique Pharmacokinetic Profile of USL255 Extended Release Topiramate
6. International Drug & Explosives Detection Company IDenta Corp. Releases Information to OTC markets.
7. ShelfX Releases A Fridge That Knows What You Took
8. Techne Corporation Releases Unaudited Third Quarter and Nine Month Fiscal Year 2012 Results
9. GenVec To Release First Quarter 2012 Financial Results And Conduct A Conference Call On May 10, 2012
10. Stereotaxis Releases V-Sono™ Intracardiac Echocardiography Module for the Vdrive™ Remote Navigation System
11. Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 15, 2012; Conference Call set for 3:30 p.m. ET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , June 27, 2016  VMS Rehab Systems, ... Board will take whatever measures required to build a ... stock which is currently listed on the OTC Markets-pink ... Company Chairman and CEO, "We are seeing an anomaly ... to understand, not only by the Company, but shareholders ...
(Date:6/24/2016)... , June 24, 2016  Consumers have ... and regulators/payers have placed more emphasis on patient ... patient support programs in the pharmaceutical industry have ... medications. Consequently, pharmaceutical companies are focusing on becoming ... are providing products and services that improve health. ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
Breaking Medicine Technology:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Global law ... magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this recognition are ... , Seven Greenberg Traurig Shareholders received special honors as members of this year’s Legal ...
(Date:6/24/2016)... ... June 24, 2016 , ... Comfort Keepers® of San Diego, CA ... the Road To Recovery® program to drive cancer patients to and from their cancer ... ensure the highest quality of life and ongoing independence. Getting to and from ...
(Date:6/24/2016)... Plano, TX (PRWEB) , ... June 24, 2016 , ... ... taking part in Genome magazine’s Code Talker Award, an essay contest in which patients ... for an award to be presented at the 2016 National Society of Genetic Counselors ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Living, is proud to recognize Dr. Barry M. Weintraub as a prominent plastic ... most beautiful women in the world, and the most handsome men, look naturally ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital Partners, ... economy by obtaining investment capital for emerging technology companies. SCP has delivered ... already resulted in more than a million dollars of capital investment for five ...
Breaking Medicine News(10 mins):